Indian Carfilzomib Exporters: Complete Supplier Ranking with Market Share — 105 Manufacturers (2026) — TransData Nexus

Q: Who is the largest carfilzomib buyer importing from India?

ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA (ECUADOR) is the largest carfilzomib importer from India with a 4.4% market share and import value of $53.3K.

Q: How many carfilzomib buyers import from India?

There are 105 active carfilzomib buyers importing from India, with a combined import market of $1.2M across 203 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top carfilzomib buyers from India?

The top 5 carfilzomib buyers — ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA, VLADIMIR GASPARYAN, EVEREST BANK LTD, RAFTAR MARIME FZE, VLADIMIR GASPARYAN APP — together control 10.4% of total carfilzomib import value from India.

Suresh Sormare

Carfilzomib

India Pharmaceutical Trade Intelligence

$1.2M65 Suppliers47 CountriesHS 30049049

ExportsIndia → RUSSIA60.7%India → CHILE7.4%

ImportsIRELAND → India$9.4M CANADA → India$518.8K

#1 Supplier: MSN LABORATORIES

Market Analysis: Top Importing Countries & Their Importers

1Russia

Russia emerges as the first largest importing country, achieving a total trade value of $737.1K through 0 shipments. This represents a market share of 60.7% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Russia demonstrates strong market positioning with an average shipment value of $737.1K, indicating premium pricing strategy compared to the market average of $6.0K.

Russia is a key market for Carfilzomib imports, representing 60.7% of total trade value.

Primary Market

Secondary Market

2Chile

Chile emerges as the second largest importing country, achieving a total trade value of $89.7K through 0 shipments. This represents a market share of 7.4% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Chile demonstrates strong market positioning with an average shipment value of $89.7K, indicating premium pricing strategy compared to the market average of $6.0K.

Chile is a key market for Carfilzomib imports, representing 7.4% of total trade value.

Buyer Segment Analysis

TransData Nexus Carfilzomib buyer market intelligence

1Buyer Segment Analysis

Carfilzomib, a proteasome inhibitor used in the treatment of multiple myeloma, has been exported from India to 47 countries, involving 105 buyers across 203 shipments totaling $1.2 million. The repeat buyer rate stands at 36.2%, indicating a moderate level of recurring demand.

Buyer Segments:

1. Distributors: Entities that purchase Carfilzomib for resale to healthcare providers. For instance, ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA in Ecuador, the top buyer with purchases totaling $0.05 million, likely operates as a distributor, supplying the drug to local hospitals and clinics.

2. Hospital Groups: Large healthcare institutions procuring directly for patient treatment. While specific hospital groups are not identified in the top buyers, it's common for such entities to source medications directly to ensure supply chain reliability.

3. Retail Chains: Pharmacy chains that stock Carfilzomib for outpatient dispensing. The data does not specify retail chains among the top buyers, suggesting that purchases are predominantly made by larger entities.

4. Government Procurement: National health agencies or international organizations like UNICEF and the Global Fund that acquire medications for public health programs. The absence of such buyers in the top 10 suggests that Carfilzomib procurement may be more decentralized or handled through other channels in these regions.

5. Re-exporters: Companies that import Carfilzomib for the purpose of exporting to other markets. RAFTAR MARIME FZE in the United Arab Emirates, with purchases totaling $0.02 million, may function as a re-exporter, leveraging the UAE's strategic position as a trade hub.

6. Contract Manufacturers: Firms that produce Carfilzomib under contract for other companies. The provided data does not indicate contract manufacturers among the top buyers, implying that Indian exporters are supplying finished products directly to end-users or distributors.

Country-Specific Import Regulations

TransData Nexus Carfilzomib buyer market intelligence

1Country-Specific Import Regulations

Understanding the regulatory landscape is crucial for market entry and compliance. Below is an overview of the import regulations for Carfilzomib in the top five importing countries:

1. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires submission of a registration dossier, including clinical trial data, quality documentation, and labeling information.

Estimated Timeline: Approximately 12-18 months, depending on the completeness of the submission and any additional requirements.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are subject to a standard import duty; specific rates should be confirmed with the Federal Customs Service.

2. Chile:

Regulatory Authority: Instituto de Salud Pública de Chile (ISP).

Demand Drivers & Market Opportunity

TransData Nexus Carfilzomib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Carfilzomib in importing countries is influenced by several factors:

1. Disease Prevalence: Multiple myeloma, the primary indication for Carfilzomib, has varying prevalence rates globally. Countries with higher incidence rates exhibit greater demand for effective treatments.

2. Government Healthcare Programs: National health initiatives aimed at improving cancer care accessibility contribute to increased procurement of oncology drugs. For example, countries expanding universal health coverage are more likely to include advanced therapies like Carfilzomib in their formularies.

3. WHO Essential Medicines List (EML): Inclusion of a drug in the WHO EML can influence national procurement decisions. While Carfilzomib is not currently listed, its therapeutic significance may prompt consideration for inclusion, thereby affecting demand.

4. Tender-Based Purchasing: Many countries utilize tender systems for pharmaceutical procurement, focusing on cost-effectiveness and supply reliability. Participation in such tenders can significantly impact market opportunities for Carfilzomib suppliers.

Given the presence of 105 buyers across 47 countries, the market for Carfilzomib demonstrates a broad international reach. Targeted engagement with healthcare providers, alignment with national health priorities, and compliance with regulatory requirements are essential strategies for capitalizing on these market opportunities.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Carfilzomib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest carfilzomib buyer importing from India?

Based on import volume and value, ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA (ECUADOR) leads with $53.3K in imports and a 4.4% market share — the highest of any single carfilzomib importer. VLADIMIR GASPARYAN (ARMENIA) and EVEREST BANK LTD (NEPAL) are the next largest buyers.

QHow many companies buy carfilzomib from India?

There are 105 active carfilzomib buyers importing from India, with a combined market of $1.2M across 203 shipments to 47 countries. The top 5 buyers hold 10.4% of total import value, while the remaining 100 buyers handle the other 89.6%.

QWhich countries import the most carfilzomib from India?

The top importing countries for carfilzomib from India are Russia (60.7%), Chile (7.4%), Ecuador (4.4%), United Arab Emirates (4.0%), Armenia (3.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of carfilzomib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for carfilzomib from India?

The average import transaction value for carfilzomib from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Carfilzomib buyer market intelligence

1Buyer Segment Analysis

Buyer Segments:

Country-Specific Import Regulations

TransData Nexus Carfilzomib buyer market intelligence

1Country-Specific Import Regulations

Understanding the regulatory landscape is crucial for market entry and compliance. Below is an overview of the import regulations for Carfilzomib in the top five importing countries:

1. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Import Registration Process: Requires submission of a registration dossier, including clinical trial data, quality documentation, and labeling information.

Estimated Timeline: Approximately 12-18 months, depending on the completeness of the submission and any additional requirements.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049049 are subject to a standard import duty; specific rates should be confirmed with the Federal Customs Service.

2. Chile:

Regulatory Authority: Instituto de Salud Pública de Chile (ISP).

Demand Drivers & Market Opportunity

TransData Nexus Carfilzomib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Carfilzomib in importing countries is influenced by several factors:

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Carfilzomib

Carfilzomib

Who Buys Carfilzomib from India — 105 Importers Behind a $1.2M Market

Top Carfilzomib Importers — Ranked by Import Value

Top Carfilzomib Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Carfilzomib — and from which countries?

Carfilzomib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Russia

2Chile

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Carfilzomib Buyers & Importers

QWho is the largest carfilzomib buyer importing from India?

QHow many companies buy carfilzomib from India?

QWhich countries import the most carfilzomib from India?

QWhat is the average import order value for carfilzomib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Ecuador

4United Arab Emirates

5Armenia

Analysis Methodology